Precision Business Insights has published a report on the global precision medicine market, estimating its value at USD 85,867 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 3.9% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/precision-medicine-market
The precision medicine industry focuses on adapting medical treatments to specific genetic, environmental, and lifestyle characteristics. Precision medicine, unlike traditional one-size-fits-all treatments, uses genetics, bioinformatics, and sophisticated diagnostics to give customized medications that increase efficacy while minimizing side effects.
Drivers:
- Increased prevalence of cancer, cardiovascular, and metabolic disorders requiring personalized care
- Demand for tailored solutions improving outcomes and reducing trial-and-error treatments
The global precision medicine market segmentation:
1) By Product Type: Consumables, Instruments, and Services
2) By Type: Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral drugs, and Others
3) By Indications: Oncology, Rare Diseases, Infectious diseases, Hematological disorders, and Others
4) By Drugs: Alectinib, Osimertinib, Mepolizumab, Aripiprazole Lauroxil, and Others
5) By End-Users: Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, and Others
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=348983
Regional Overview:
The report also examines the current concerns and their Future Effects on the precision medicine market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the precision medicine market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like AstraZeneca plc, Bayer AG, bioMérieux SA, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Pfizer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
